Klabin S.A (KLBN3)
B3 Stock Exchange · Brazil · prices in BRL · close of 23 Oct 2026
Key indicators
| Last close | BRL 3.700 |
|---|---|
| 52-week range | 3.230 – 4.240 |
| Return, 1 month / 3 months | −6.3% / +3.9% |
| Return, 1 year / 3 years | +7.5% / +6.5% |
| Trend | Below its 200-day average |
| RSI (14) | 40 |
| Volatility (1 year) | 23.1% |
| Worst drawdown (1 year) | -23.0% |
| Average daily value traded | 2.62M BRL |
| Dividend yield | 6.4% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Klabin S.A. is a Brazilian forest products company that grows planted eucalyptus and pine and turns the wood into paper and packaging. It makes containerboard, kraft paper and corrugated boxes for customers in food, beverage, consumer goods and industrial markets, and also produces wood products and sells some timber. The company is based in São Paulo and operates mills and forest operations across Brazil, serving both domestic and export customers.
On this site Klabin S.A appears as a stock on the B3 Stock Exchange (Brazil), code KLBN3, with prices in Brazilian reais (BRL). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Klabin S.A (KLBN3) trades on the B3 Stock Exchange in Brazil. It last closed at BRL 3.700 on 23 October 2026.
Its price-based Market X-Ray is 62 out of 100 (a fair price profile), ranking 352 of 1,455 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 7.5% and over the last three months it rose 3.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on B3 Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 52 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -0.3% | ||
| From 52-week high | -12.1% | ||
| Momentum | 54 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 3.9% | ||
| 6-month return | 2.2% | ||
| 12-month return, skipping the last month | 14.8% | ||
| Stability (higher is calmer) | 77 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 23.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -23.0% | ||
| Liquidity | 80 · Strong | Trades actively. | |
| Average daily value traded | 2.62M BRL | ||
| Zero-volume days | 0.0% | ||
| Income | 45 · Weak | Dividend is small or irregular. | |
| Dividend yield | 6.4% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | +0.0% |
|---|---|
| 1 month | −6.3% |
| 3 months | +3.9% |
| 6 months | +2.2% |
| 1 year | +7.5% |
| 3 years | +6.5% |
| 5 years | −8.7% |
Signals
| 50-day / 200-day average | 3.831 / 3.710 |
|---|---|
| Golden / death cross (60 days) | Golden, 25 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.099 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 15 Dec 2025 | BRL 0.1842 |
| 7 Nov 2025 | BRL 0.0527 |
| 8 Aug 2025 | BRL 0.0507 |
| 13 May 2025 | BRL 0.0462 |
| 5 Mar 2025 | BRL 0.0090 |
| 16 Dec 2024 | BRL 0.0429 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on B3 Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.